To ask the Scottish Executive what recent research has been undertaken to assess the epidemiology and incidence of myeloma in Scotland and, if such research has been undertaken, what percentage of myeloma patients are (a) men and (b) women; how many people were diagnosed with (a) myeloma and (b) multiple myeloma in (i) 1975, (ii) 1980, (iii) 1985, (iv) 1990, (v) 1995, (vi) 2000 and (vii) 2001; what percentage of myeloma patients are under (a) 30, (b) 40 and (c) 50, and in what areas there are clusters of myeloma patients.
Data on the incidence of, and mortality from, multiple myeloma and malignant plasma cell neoplasms, broken down by age, sex, year of diagnosis/death, and geographic area are published on the website of NHS National Services Scotland, Information Services (ISD) at:
www.isdscotland.org.
Scottish Cancer Registry data indicate that 161 men and 129 women were diagnosed with multiple myeloma in Scotland in the year 2001 (total 290; 56% men, 44% women).
The terms "myeloma" and "multiple myeloma" are generally regardedas synonymous. Solitary tumours of plasma cells can occur, but much less commonlythan multiple myeloma. In the context of the International Classification of Diseases, both conditions come under the general heading of "Multiple myeloma and malignant plasma cell neoplasms".
The number of persons diagnosed with multiple myeloma in Scotland forselected years were as follows:
Year | No. of New Cases |
1975 | 175 |
1980 | 262 |
1985 | 242 |
1990 | 288 |
1995 | 323 |
2000 | 307 |
2001 | 290 |
In 2001, less than 1% of patients with multiple myeloma were aged less than 30 years at diagnosis. Less than 1% were aged less than 40 years. Only 2.1% were aged less than 50 years.
During the period 1997-2001, the incidence of multiple myeloma and malignant plasma cell neoplasms combined in men did not differ in a statistically significant sense between the 15 Scottish NHS board areas of residence compared to Scotland as a whole. In women, however, compared to Scotland as a whole, incidence was statistically significantly higher in the Grampian and WesternIsles Health Board areas, and significantly lower in the Greater Glasgow and Tayside Health Board areas.